ID   PPMI.I.1155.1
AC   CVCL_D5XK
SY   PPMI3471; PPMI_3471; CDIi047-A; FCDI_11341
DR   BioSamples; SAMEA115473828
DR   hPSCreg; CDIi047-A
RX   PubMed=35895835;
RX   PubMed=36950378;
WW   https://www.ppmi-info.org/access-data-specimens/download-data
WW   https://www.michaeljfox.org/sites/default/files/media/document/2018%20-%20PDTC%20-%20NKP%20Poster%20on%20iPSCs.pdf
CC   Part of: Parkinson's Progression Marker Initiative (PPMI) cell line panel.
CC   Population: Caucasian, not Hispanic.
CC   Omics: Genome sequenced.
CC   Miscellaneous: PPMI study cohort PD, PPMI study subgroup sporadic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 02-05-24; Version: 1
//
RX   PubMed=35895835; DOI=10.1126/scitranslmed.abp8869;
RA   Langston R.G., Beilina A., Reed X., Kaganovich A., Singleton A.B.,
RA   Blauwendraat C., Gibbs J.R., Cookson M.R.;
RT   "Association of a common genetic variant with Parkinson's disease is
RT   mediated by microglia.";
RL   Sci. Transl. Med. 14:eabp8869.1-eabp8869.12(2022).
//
RX   PubMed=36950378; DOI=10.1016/j.xgen.2023.100261;
RA   Bressan E., Reed X., Bansal V., Hutchins E., Cobb M.M., Webb M.G.,
RA   Alsop E., Grenn F.P., Illarionova A., Savytska N., Violich I.,
RA   Broeer S., Fernandes N., Sivakumar R., Beilina A., Billingsley K.J.,
RA   Berghausen J., Pantazis C.B., Pitz V., Patel D., Daida K.,
RA   Meechoovet B., Reiman R., Courtright-Lim A., Logemann A., Antone J.,
RA   Barch M., Kitchen R., Li Y., Dalgard C.L., Rizzu P., Hernandez D.G.,
RA   Hjelm B.E., Nalls M.A., Gibbs J.R., Finkbeiner S., Cookson M.R.,
RA   Van Keuren-Jensen K., Craig D.W., Singleton A.B., Heutink P.,
RA   Blauwendraat C.;
RT   "The Foundational Data Initiative for Parkinson Disease: enabling
RT   efficient translation from genetic maps to mechanism.";
RL   Cell Genom 3:100261.1-100261.25(2023).
//